Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

Expanding Access to Fight the Obesity Epidemic

In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses how access to these weight loss drugs can help the obesity epidemic.

Psychedelic Medicine Could Fill Care Gap in Psychiatric Care

However, psychedelic medicine has a variety of barriers, including historical perception, access challenges, legal obstacles, and ethical questions.

In Battle Over Health Care Costs, Private Equity Plays Both Sides

As medical practices owned by private equity firms fuel overbilling, a payment tool also backed by such investors helps insurers boost their profits.

MedQuest Names Aalpen Patel Chief Clinical and Innovation Officer

MedQuest Associates (MedQuest), has selected Dr. Aalpen Patel as Chief Clinical and Innovation Officer. Dr. Patel joined on March 18 in a new role overseeing all functions related to clinical practices and innovation in product development and care delivery. He reports to CEO Jason Howard and serves on the company’s Executive Leadership Council.

Vani P. on LinkedIn:

Absolutely! Embracing patient-centric strategies and innovative tools enhances adherence and ultimately transforms the healthcare journey.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs